Combined Anabolic Therapy

Who May Qualify: - women aged 45+ - postmenopausal - osteoporotic with high risk of fracture Who Should NOT Join This Trial: - no significant previous use of bone health modifying treatments - known congenital or acquired bone disease other than osteoporosis - significant renal disease, liver disease, cardiopulmonary disease, or psychiatric disease - abnormal calcium or parathyroid hormone level - serum vitamin D \<20 ng/dL - anemia (hematocrit \<32%) - history of malignancy (except non-melanoma skin carcinoma) - excessive alcohol use or substance abuse - known contraindications to romosozumab or teriparatide Always talk to your doctor about whether this trial is right for you.